| Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial A Nichol, C French, L Little, S Haddad, J Presneill, Y Arabi, M Bailey, ... The Lancet 386 (10012), 2499-2506, 2015 | 258 | 2015 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 52 | 2023 |
| MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease MM Ruissen, AL Mak, U Beuers, ME Tushuizen, AG Holleboom European journal of endocrinology 183 (3), R57-R73, 2020 | 49 | 2020 |
| Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: The Amsterdam NAFLD‐NASH cohort MA Troelstra, JJ Witjes, AM van Dijk, AL Mak, O Gurney‐Champion, ... Journal of magnetic resonance imaging 54 (6), 1937-1949, 2021 | 35 | 2021 |
| Systematic review with meta-analysis: diagnostic accuracy of pro-C3 for hepatic fibrosis in patients with non-alcoholic fatty liver disease AL Mak, J Lee, AM van Dijk, Y Vali, GP Aithal, JM Schattenberg, ... Biomedicines 9 (12), 1920, 2021 | 30 | 2021 |
| Systematic review with meta-analyses: diagnostic accuracy of FibroMeter tests in patients with non-alcoholic fatty liver disease AM Van Dijk, Y Vali, AL Mak, J Lee, ME Tushuizen, MH Zafarmand, ... Journal of clinical medicine 10 (13), 2910, 2021 | 29 | 2021 |
| Cost-effectiveness of erythropoietin in traumatic brain injury: a multinational trial-based economic analysis RJ Knott, A Harris, A Higgins, A Nichol, C French, L Little, S Haddad, ... Journal of neurotrauma 36 (17), 2541-2548, 2019 | 17 | 2019 |
| Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach D Stols-Gonçalves, AL Mak, MS Madsen, EWJ van der Vossen, ... Gut Microbes 15 (1), 2223330, 2023 | 10 | 2023 |
| Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease MA Troelstra, AM Van Dijk, JJ Witjes, AL Mak, D Zwirs, JH Runge, ... Frontiers in physiology 13, 942495, 2022 | 8 | 2022 |
| Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activation CB Woda, S Bruneau, AL Mak, Z Haskova, K Liu, CC Ghosh, DM Briscoe Biochemical and biophysical research communications 519 (4), 667-673, 2019 | 8 | 2019 |
| EPO-TBI investigators; ANZICS clinical trials group. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial A Nichol, C French, L Little, S Haddad, J Presneill, Y Arabi, M Bailey, ... Lancet 386 (10012), 2499-506, 2015 | 6 | 2015 |
| Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study AM van Dijk, Y Vali, AL Mak, H Galenkamp, M Nieuwdorp, ... Hepatology communications 7 (1), e2109, 2023 | 5 | 2023 |
| Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH-2): The exploratory health-related quality of life and patient-reported functional outcomes of a … GP Slobogean, S Sprague, S Bzovsky, T Scott, L Thabane, ... Injury 52 (10), 3051-3059, 2021 | 5 | 2021 |
| Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis FE Mózes, JA Lee, Y Vali, EA Selvaraj, ANA Jayaswal, J Boursier, ... Liver international, 2024 | 1 | 2024 |
| Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease AL Mak, N Wassenaar, AM van Dijk, M Troelstra, V Houttu, K van Son, ... JHEP Reports 6 (3), 100998, 2024 | 1 | 2024 |
| Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver … KC van Son, AM van Dijk, S Driessen, AL Mak, JJ Witjes, VAT Houttu, ... Clinical Chemistry and Laboratory Medicine (CCLM), 2024 | | 2024 |
| Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes CM Fuhri Snethlage, AS Meijnikman, AL Mak, E Rampanelli, B Voermans, ... European journal of endocrinology, lvae043, 2024 | | 2024 |
| Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated … AL Mak, QJJ Augustijn, CJF Heymann, S Havik, X Verdoes, ... International journal of molecular sciences 25 (6), 3481, 2024 | | 2024 |
| HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD FE Mozes, S Kaur, Y Vali, O Alzoubi, VWS Wong, G Li, GLHC Wong, ... HEPATOLOGY 78, S971-S974, 2023 | | 2023 |
| Histologically assessed fibrosis is the main determinant of prognosis in patients in NAFLD F Emil Mozes, S Kaur, Y Vali, O Alzoubi, VWS Wong, G Li, CW GL-H, ... | | 2023 |
